Literature DB >> 27044565

Follow-up of the 1977 Georgia Outbreak of Toxoplasmosis.

Jeffrey L Jones1, Ricardo B Akstein1, Michele C Hlavsa1, Adriana S Lopez1, Mariana Wilson1, Gary N Holland2.   

Abstract

In 1977, an outbreak of toxoplasmosis occurred among 37 persons associated with exposure to an indoor horse arena. Cat feces containing the organism were most likely stirred up when horses ran on the dirt floor, and were inhaled or ingested by riders and observers. After 25 or more years, we attempted to locate persons from the outbreak and offer them an eye examination. Of the 37 persons in the outbreak, 18 (49%) were located; four had died, and the remaining 14 agreed to an examination. Among the 14 persons examined, three (21%) were found to have lesions typical of toxoplasmic retinochoroiditis. If these three persons were the only ones with ocular disease among the 37 persons in the outbreak, the disease rate would still be high (8%). As a result of exposure to Toxoplasma gondii during this outbreak, a relatively high percentage of persons developed ocular disease. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27044565      PMCID: PMC4889747          DOI: 10.4269/ajtmh.15-0919

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  8 in total

1.  An epidemic of toxoplasmosis: lessons from Coimbatore, India.

Authors:  Gary N Holland
Journal:  Arch Ophthalmol       Date:  2010-01

2.  Ocular Involvement Following Postnatally Acquired Toxoplasma gondii Infection in Southern Brazil: A 28-Year Experience.

Authors:  Tiago E F Arantes; Claudio Silveira; Gary N Holland; Cristina Muccioli; Fei Yu; Jeffrey L Jones; Raquel Goldhardt; Kevan G Lewis; Rubens Belfort
Journal:  Am J Ophthalmol       Date:  2015-03-03       Impact factor: 5.258

3.  Epidemic toxoplasmosis associated with infected cats.

Authors:  S M Teutsch; D D Juranek; A Sulzer; J P Dubey; R K Sikes
Journal:  N Engl J Med       Date:  1979-03-29       Impact factor: 91.245

4.  Toxoplasma gondii isolated from amniotic fluid.

Authors:  S M Teutsch; A J Sulzer; J E Ramsey; W A Murray; D D Juranek
Journal:  Obstet Gynecol       Date:  1980-03       Impact factor: 7.661

5.  Lymphocyte proliferative responsiveness in 31 patients after an outbreak of toxoplasmosis.

Authors:  S E Maddison; S B Slemenda; S M Teutsch; K W Walls; I G Kagan; W R Mason; F Bell; J Smith
Journal:  Am J Trop Med Hyg       Date:  1979-11       Impact factor: 2.345

6.  Acquired toxoplasmosis.

Authors:  R B Akstein; L A Wilson; S M Teutsch
Journal:  Ophthalmology       Date:  1982-12       Impact factor: 12.079

7.  Characterization of Toxoplasma gondii isolates from an outbreak of toxoplasmosis in Atlanta, Georgia.

Authors:  J P Dubey; S P Sharma; D D Juranek; A J Sulzer; S M Teutsch
Journal:  Am J Vet Res       Date:  1981-06       Impact factor: 1.156

8.  Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease.

Authors:  Gary N Holland
Journal:  Am J Ophthalmol       Date:  2003-12       Impact factor: 5.258

  8 in total
  3 in total

Review 1.  Drugs in development for toxoplasmosis: advances, challenges, and current status.

Authors:  P Holland Alday; Joseph Stone Doggett
Journal:  Drug Des Devel Ther       Date:  2017-01-25       Impact factor: 4.162

2.  Toxoplasma gondii infection in domestic and wild felids as public health concerns: a systematic review and meta-analysis.

Authors:  Kareem Hatam-Nahavandi; Rafael Calero-Bernal; Mohammad Taghi Rahimi; Abdol Sattar Pagheh; Mehdi Zarean; Asiyeh Dezhkam; Ehsan Ahmadpour
Journal:  Sci Rep       Date:  2021-05-04       Impact factor: 4.379

3.  Viral metagenomics performed in patients with acute febrile syndrome during Toxoplasma gondii outbreak in south Brazil.

Authors:  Rafael Dos Santos Bezerra; Cristiane Fração Diefenbach; Dalnei Veiga Pereira; Simone Kashima; Svetoslav Nanev Slavov
Journal:  Braz J Infect Dis       Date:  2020-05-15       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.